JanOne Inc. Announces the Issuance of U.S. Patent Covering a Method of Improving Nerve Function Using JAN101PRNewsWire • 06/07/22
ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contract in Virginia and North Carolina With Total Estimated Value of $1.6 Million for Work through 2023PRNewsWire • 12/16/21
JanOne Enters Option Agreement For Rights To Novel Strategy To Reduce Methamphetamine UseBenzinga • 12/07/21
JanOne Inc. Acquires an Option for the Rights to a Worldwide, Exclusive License for a Novel Strategy for Treating Methamphetamine Use DisorderPRNewsWire • 12/07/21
ARCA Recycling, a Subsidiary of JanOne Inc., Launches Two Recycling Programs in California in Effort to Reduce GHG EmissionsPRNewsWire • 10/27/21
ARCA Recycling, a Subsidiary of JanOne Inc., Sees Major Increase in Appliance Replacement Contracts, Estimated to Push Revenue of Replacement Programs to Nearly $20 Million, in Addition to Recycling BusinessPRNewsWire • 10/19/21
ARCA Recycling, a Subsidiary of JanOne Inc., Opens Recycling Center in Michigan to Support New Multi-Year Contracts Totaling Millions in RevenuePRNewsWire • 10/12/21
ARCA Recycling, a Subsidiary of JanOne Inc., Awarded Recycling Contracts in Pennsylvania With Total Estimated Value of 20 Million Dollars for Work in the State to Continue Through 2026PRNewsWire • 10/07/21
ARCA Recycling, a Subsidiary of JanOne Inc., Opens New Pennsauken, NJ, Recycling Center, Launches New Recycling ProgramsPRNewsWire • 09/30/21
JanOne Encouraged By Recent FDA Communications Regarding Phase 2B Clinical Trial Design of Lead Drug Candidate JAN101PRNewsWire • 09/28/21
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease PatientsPRNewsWire • 07/22/21
JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial SitesPRNewsWire • 06/23/21
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA FilingPRNewsWire • 06/22/21
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory BoardPRNewsWire • 06/15/21
JanOne Advances Toward Initiation of Phase 2b Peripheral Artery Disease (PAD) Trial for Lead Product Candidate JAN101PRNewsWire • 06/08/21